Thermo Fisher Scientific has expanded its Oncomine portfolio with new assays for liquid biopsy and immuno-oncology for clinical research. The company also introduced its next generation Ion AmpliSeq HD technology, which adds customizable design capabilities to solid tumor and cell-free DNA panels.   The Ion Torrent Oncomine Pan-Cancer Cell-Free Assay enables reproducible detection and analysis of tumor DNA and RNA across all major classes of somatic mutations from a single vial of blood within...